naltrexone and memantine

naltrexone has been researched along with memantine in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (27.27)	29.6817
2010's	7 (63.64)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bespalov, A; Danysz, W; Kashkin, V; Malyshkin, A; Neznanova, O; Sukhotina, I; Zakharova, E	1
Kuzmin, A; Liljequist, S; Stenback, T	1
Bristow, RE; Grahame, NJ; Heighton, ME; Oberlin, BG	1
Bisaga, A; Carpenter, KM; Cheng, WY; Levin, FR; Mariani, JJ; Nunes, EV; Raby, WN; Sullivan, MA	1
Cavallo, DA; Franco, N; Gueorguieva, R; Krishnan-Sarin, S; Krystal, JH; O'Malley, SS; Pittman, B; Shi, J; Tetrault, JM	1
Brown, JN; Elias, AM; Pepin, MJ	1

Reviews

2 review(s) available for naltrexone and memantine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Adjunctive memantine for opioid use disorder treatment: A systematic review. Journal of substance abuse treatment, 2019, Volume: 107 Topics: Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Substance Withdrawal Syndrome	2019

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Adjunctive memantine for opioid use disorder treatment: A systematic review.

Journal of substance abuse treatment, 2019, Volume: 107

Topics: Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Substance Withdrawal Syndrome

2019

Trials

2 trial(s) available for naltrexone and memantine

Article	Year
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug and alcohol dependence, 2011, Dec-01, Volume: 119, Issue:1-2 Topics: Adult; Disease Progression; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Medication Adherence; Memantine; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Placebos; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult	2011
Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020, Volume: 45, Issue:2 Topics: Adult; Alcohol Drinking; Cross-Over Studies; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; Naltrexone; Narcotic Antagonists; Young Adult	2020

Article

Year

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.

Drug and alcohol dependence, 2011, Dec-01, Volume: 119, Issue:1-2

Topics: Adult; Disease Progression; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Medication Adherence; Memantine; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Placebos; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult

2011

Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020, Volume: 45, Issue:2

Topics: Adult; Alcohol Drinking; Cross-Over Studies; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; Naltrexone; Narcotic Antagonists; Young Adult

2020

Other Studies

7 other study(ies) available for naltrexone and memantine

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats. Behavioural pharmacology, 2004, Volume: 15, Issue:4 Topics: Acamprosate; Animals; Choice Behavior; Ethanol; Male; Memantine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Saccharin; Substance Withdrawal Syndrome; Sweetening Agents; Taurine	2004
Memantine enhances the inhibitory effects of naltrexone on ethanol consumption. European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3 Topics: Alcohol Drinking; Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Male; Memantine; Models, Animal; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reinforcement, Psychology; Self Administration	2008
Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice. Alcoholism, clinical and experimental research, 2010, Volume: 34, Issue:8 Topics: Alcohol Drinking; Alcoholism; Amphetamine; Animals; Behavior, Addictive; Choice Behavior; Female; Impulsive Behavior; Male; Memantine; Mice; Naltrexone; Reaction Time	2010